Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Rimegepant Sulfate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 11,778Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rubin’s Generics Rimegepant Receives Tentative Approval in US
    Rubin’s Generics Rimegepant Receives Tentative Approval in US

    14 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219440

    FDA
    14 Jan 2026
    Share Share
    Pfizer Introduces Rimegepant Oral Migraine Medication In India
    Pfizer Introduces Rimegepant Oral Migraine Medication In India

    17 Nov 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/pfizer-launches-new-rimegepant-oral-medication-in-india-for-migraine/

    EXPRESSPHARMA
    17 Nov 2025
    Share Share
    Pfizer to press pause on large M&A deals, CEO says
    Pfizer to press pause on large M&A deals, CEO says

    11 Jun 2024

    // Fraiser Kansteiner FIERCE PHARMA

    https://www.fiercepharma.com/pharma/pfizer-ceo-says-company-needs-take-breathing-period-after-massive-ma-stretch

    Fraiser Kansteiner FIERCE PHARMA
    11 Jun 2024
    Share Share
    FDA Confirms Para IV Patent Litigation for Rimegepant Sulfate (Nurtec ODT) Tablets
    FDA Confirms Para IV Patent Litigation for Rimegepant Sulfate (Nurtec ODT) Tablets

    26 Apr 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-para-iv-patent-litigation-for-rimegepant-sulfate-nurtec-odt-tablets-71965.pdf

    FDA
    26 Apr 2024
    Share Share
    Lady Gaga returns in a new Nurtec migraine ad for Pfizer
    Lady Gaga returns in a new Nurtec migraine ad for Pfizer

    09 Apr 2024

    // Beth Snyder Bulik ENDPTS

    https://endpts.com/lady-gaga-returns-in-a-new-nurtec-migraine-ad-for-pfizer/

    Beth Snyder Bulik ENDPTS
    09 Apr 2024
    Share Share
    Pfizer's Vydura gets NICE nod to treat episodic migraine attacks
    Pfizer's Vydura gets NICE nod to treat episodic migraine attacks

    13 Sep 2023

    // Kevin Dunleavy FIERCE PHARMA

    https://www.fiercepharma.com/pharma/late-party-nice-finally-signs-pfizers-nurtec-treat-migraine-attacks

    Kevin Dunleavy FIERCE PHARMA
    13 Sep 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.